Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2928

Actual shortage: 212 (7%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 2706 (92%)

Discontinuation Reports

300

To be discontinued: 2 (1%)
Discontinued: 298 (99%)
Reversed: 0 (0%)

Late reports

362 (11%)

Overdue reports

85 (40%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65993
ACT METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-28 2024-05-09 223862
ACT METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65999
ACT NABILONE 0.5MG CAPSULE Resolved 2020-04-16 2021-09-23 112394
ACT NABILONE 0.5MG CAPSULE Resolved 2019-12-19 2020-03-12 101740
ACT NABILONE 1MG CAPSULE Resolved 2019-12-19 2020-03-12 101730
ACT NABILONE 0.5MG CAPSULE Resolved 2020-07-16 2020-08-07 120459
ACT NABILONE 1MG CAPSULE Resolved 2019-10-17 2020-03-12 96733
ACT OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-01-24 99965
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-01-24 99968
ACT OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-09-05 2019-10-26 93156
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-17 2018-06-15 3357
ACT OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-05-24 2018-06-15 10972
ACT OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-05-24 2018-10-11 10975
TEVA-OLMESARTAN 20MG TABLET Resolved 2018-10-22 2020-06-11 65350
TEVA-OLMESARTAN 40MG TABLET Resolved 2018-10-22 2020-06-11 65340
TEVA-OLMESARTAN / HCTZ 12.5MG 20MG TABLET Resolved 2018-10-22 2020-06-11 65343
TEVA-OLMESARTAN / HCTZ 25MG 40MG TABLET Resolved 2018-10-22 2020-06-11 65346
TEVA-OLMESARTAN / HCTZ 12.5MG 40MG TABLET Resolved 2018-09-12 2020-06-11 61359
ACT OLOPATADINE 0.1% 0.1% SOLUTION Actual shortage 2018-10-23 2018-10-23 65519

Showing 181 to 200 of 2928

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-AMITRIPTYLINE 25MG TABLET Discontinued 2022-01-07 2022-01-07 152351
TEVA-AMLODIPINE 10MG TABLET Discontinued 2020-07-10 2020-07-10 120039
TEVA-AMLODIPINE 5MG TABLET Discontinued 2020-07-10 2020-07-10 120036
TEVA-ARIPIPRAZOLE 5MG TABLET Discontinued 2020-01-24 2020-01-24 104283
TEVA-ARIPIPRAZOLE 30MG TABLET Discontinued 2020-06-11 2020-06-11 117541
TEVA-ARIPIPRAZOLE 10MG TABLET Discontinued 2020-06-11 2020-06-11 117535
TEVA-ARIPIPRAZOLE 15MG TABLET Discontinued 2020-06-11 2020-06-11 117538
TEVA-ARIPIPRAZOLE 20MG TABLET Discontinued 2020-06-11 2020-06-11 117532
TEVA-ARIPIPRAZOLE 2MG TABLET Discontinued 2020-05-14 2020-05-14 115085
TEVA-ARIPIPRAZOLE 5MG TABLET Discontinued 2020-01-24 2020-01-24 104263
TEVA-ARIPIPRAZOLE 15MG TABLET Discontinued 2019-10-25 2019-10-26 97264
TEVA-ARIPIPRAZOLE 20MG TABLET Discontinued 2019-10-25 2019-10-26 97267
TEVA-ATENOLOL 100MG TABLET Discontinued 2020-02-13 2020-02-13 106145
TEVA-ATENOLOL 50MG TABLET Discontinued 2020-02-13 2020-02-13 106142
TEVA-ATENOLOL/CHLORTHALIDONE 25MG 100MG TABLET Discontinued 2020-01-21 2020-01-21 103781
TEVA-ATORVASTATIN 40MG TABLET Discontinued 2018-10-17 2018-10-17 64538
TEVA-ATORVASTATIN 40MG TABLET Discontinued 2018-10-17 2018-10-17 64541
TEVA-ATORVASTATIN 10MG TABLET Discontinued 2018-10-17 2018-10-17 64601
TEVA-ATORVASTATIN 20MG TABLET Discontinued 2018-10-17 2018-10-17 64609
TEVA-ATORVASTATIN 20MG TABLET Discontinued 2018-10-17 2018-10-17 64612

Showing 121 to 140 of 300